First SARM cycle (harm-reduction)

Harm-reduction documentation of what a typical first SARM cycle and its "on-cycle support / post-cycle therapy" actually contain — NOT a protocol or endorsement. SARMs are unapproved, gated research compounds with real risks (HPTA suppression, adverse lipids, liver injury) and rampant product mislabeling. The evidence layer here is mostly grey-market with no human approval.

Documented, not endorsed. What First SARM cycle reports taking (as of 2026-06) — not medical advice, not a recommendation. We sell nothing; each item links to its independently evidence-graded card.

At a glance

Aimed at (inferred from 7 mapped members)

⚗️ Hormones 5💪 Performance & recovery 3🧬 Longevity & healthspan 2

Evidence makeup

2 Moderate 5 Gated / research compound

5 of 7 mapped items are gated research compounds — informational only.

The stack · 7 compounds

Core

💪 Ostarine (MK-2866 / Enobosarm)research compound
Often the "beginner" SARM — still suppressive, no human approval.
Emerging 3.6no dose info

Situational

💪 LGD-4033 (Ligandrol)research compound
More suppressive SARM.
Emerging 3.5no dose info
🧪 RAD-140 (Testolone)research compound
Strongly suppressive SARM.
Emerging 3.2no dose info
🛡️ NAC
Used for liver support during a cycle.
Moderate 6.0no dose info
🫀 TUDCA
Bile-acid liver support during a cycle.
Moderate 6.0no dose info
🧬 Enclomipheneresearch compound
Used in post-cycle therapy to restart endogenous testosterone.
Emerging 4.2no dose info
🎗️ Tamoxifen (Nolvadex)research compound
SERM used in post-cycle therapy.
Moderate 5.2no dose info

“no dose info” = publicly known to take it, but no reliable dose has been stated.

Start my stack from this Compare with my stack

“Start” adds the 2 evidence-graded compounds to your own stack to edit — gated research compounds excluded. Not an endorsement.

Compare with another stack

All comparisons →

Sources: SupStack methodology (harm-reduction framing)